Editorial (Thematic Issue: Gene Therapy for Gastrointestinal and Liver Cancers: Past Experience, Current Status and Future Perspectives)

2015 ◽  
Vol 15 (2) ◽  
pp. 93-96
Author(s):  
George Wilson ◽  
Lionel Hebbard ◽  
Wei Duan ◽  
Jacob George ◽  
Liang Qiao
Cancers ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 1865 ◽  
Author(s):  
Kenya Kamimura ◽  
Takeshi Yokoo ◽  
Hiroyuki Abe ◽  
Shuji Terai

The liver is a key organ for metabolism, protein synthesis, detoxification, and endocrine function, and among liver diseases, including hepatitis, cirrhosis, malignant tumors, and congenital disease, liver cancer is one of the leading causes of cancer-related deaths worldwide. Conventional therapeutic options such as embolization and chemotherapy are not effective against advanced-stage liver cancer; therefore, continuous efforts focus on the development of novel therapeutic options, including molecular targeted agents and gene therapy. In this review, we will summarize the progress toward the development of gene therapies for liver cancer, with an emphasis on recent clinical trials and preclinical studies.


2014 ◽  
Vol 14 (6) ◽  
pp. 447-460 ◽  
Author(s):  
Kerstin Kaufmann ◽  
Maria Chiriaco ◽  
Ulrich Siler ◽  
Andrea Finocchi ◽  
Janine Reichenbach ◽  
...  

2018 ◽  
Vol 23 (37) ◽  
pp. 5760-5765 ◽  
Author(s):  
Antonio Gambardella ◽  
Angelo Labate ◽  
Laura Mumoli ◽  
Iscia Lopes-Cendes ◽  
Fernando Cendes

Sign in / Sign up

Export Citation Format

Share Document